196 related articles for article (PubMed ID: 31093793)
1. The expression of melanoma-associated antigen A (MAGE-A) in oral squamous cell carcinoma: an evaluation of the significance for tumor prognosis.
Trippel A; Halling F; Heymann P; Ayna M; Al-Nawas B; Ziebart T
Oral Maxillofac Surg; 2019 Sep; 23(3):343-352. PubMed ID: 31093793
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma.
Chen X; Wang L; Yue D; Liu J; Huang L; Yang L; Cao L; Qin G; Li A; Wang D; Wang M; Qi Y; Zhang B; van der Bruggen P; Zhang Y
Histol Histopathol; 2017 Aug; 32(8):793-803. PubMed ID: 27868181
[TBL] [Abstract][Full Text] [Related]
4. MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy.
Laban S; Giebel G; Klümper N; Schröck A; Doescher J; Spagnoli G; Thierauf J; Theodoraki MN; Remark R; Gnjatic S; Krupar R; Sikora AG; Litjens G; Grabe N; Kristiansen G; Bootz F; Schuler PJ; Brunner C; Brägelmann J; Hoffmann TK; Perner S
Oncotarget; 2017 Feb; 8(9):14719-14735. PubMed ID: 28146422
[TBL] [Abstract][Full Text] [Related]
5. Prediction of recurrence using exfoliative cytology and melanoma-associated antigen-A mRNA analysis following wide excision of oral squamous cell carcinoma: short report.
Mollaoglu N; Metzler P; Zenk J; Nkenke E; Neukam FW; Ries J
Cytopathology; 2011 Dec; 22(6):387-91. PubMed ID: 21054590
[TBL] [Abstract][Full Text] [Related]
6. Expression of melanoma-associated antigens in oral squamous cell carcinoma.
Ries J; Vairaktaris E; Mollaoglu N; Wiltfang J; Neukam FW; Nkenke E
J Oral Pathol Med; 2008 Feb; 37(2):88-93. PubMed ID: 18197853
[TBL] [Abstract][Full Text] [Related]
7. Expression of MAGE-A1-A12 subgroups in the invasive tumor front and tumor center in oral squamous cell carcinoma.
Brisam M; Rauthe S; Hartmann S; Linz C; Brands RC; Kübler AC; Rosenwald A; Müller-Richter UD
Oncol Rep; 2016 Apr; 35(4):1979-86. PubMed ID: 26820613
[TBL] [Abstract][Full Text] [Related]
8. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
9. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma.
Cuffel C; Rivals JP; Zaugg Y; Salvi S; Seelentag W; Speiser DE; Liénard D; Monnier P; Romero P; Bron L; Rimoldi D
Int J Cancer; 2011 Jun; 128(11):2625-34. PubMed ID: 20715104
[TBL] [Abstract][Full Text] [Related]
10. A novel multiple-marker method for the early diagnosis of oral squamous cell carcinoma.
Ries J; Mollaoglu N; Toyoshima T; Vairaktaris E; Neukam FW; Ponader S; Nkenke E
Dis Markers; 2009; 27(2):75-84. PubMed ID: 19893202
[TBL] [Abstract][Full Text] [Related]
11. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
12. MAGE-A antigens in patients with primary oral squamous cell carcinoma.
Müller-Richter UD; Dowejko A; Peters S; Rauthe S; Reuther T; Gattenlöhner S; Reichert TE; Driemel O; Kübler AC
Clin Oral Investig; 2010 Jun; 14(3):291-6. PubMed ID: 19488795
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy.
Ries J; Schultze-Mosgau S; Neukam F; Diebel E; Wiltfang J
Int J Oncol; 2005 Mar; 26(3):817-24. PubMed ID: 15703841
[TBL] [Abstract][Full Text] [Related]
14. Expression of MAGE-A3/6 in primary breast cancer is associated with hormone receptor negative status, high histologic grade, and poor survival.
Ayyoub M; Scarlata CM; Hamaï A; Pignon P; Valmori D
J Immunother; 2014; 37(2):73-6. PubMed ID: 24509169
[TBL] [Abstract][Full Text] [Related]
15. Expression of cancer-testis antigens MAGE-A4 and MAGE-C1 in oral squamous cell carcinoma.
Montoro JR; Mamede RC; Neder Serafini L; Saggioro FP; Figueiredo DL; Silva WA; Jungbluth AA; Spagnoli GC; Zago MA
Head Neck; 2012 Aug; 34(8):1123-8. PubMed ID: 22083937
[TBL] [Abstract][Full Text] [Related]
16. Expression of MAGE-A12 in oral squamous cell carcinoma.
Mollaoglu N; Vairaktaris E; Nkenke E; Neukam FW; Ries J
Dis Markers; 2008; 24(1):27-32. PubMed ID: 18057533
[TBL] [Abstract][Full Text] [Related]
17. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.
Laban S; Atanackovic D; Luetkens T; Knecht R; Busch CJ; Freytag M; Spagnoli G; Ritter G; Hoffmann TK; Knuth A; Sauter G; Wilczak W; Blessmann M; Borgmann K; Muenscher A; Clauditz TS
Int J Cancer; 2014 Sep; 135(5):1142-52. PubMed ID: 24482145
[TBL] [Abstract][Full Text] [Related]
20. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
